Advanced Medical Isotopes Corporation Files 510(k) Pre-Market Notification for FDA Clearance of Yttrium-90 RadioGel™ Brachytherapy Product
11/4/2013 9:40:24 AM
KENNEWICK, Wash., Nov. 3, 2013 (GLOBE NEWSWIRE) -- Advanced Medical Isotope Corporation ("AMIC") (OTCBB:ADMD), a company engaged in the development, production and distribution of medical isotopes, today announced that it has filed pre-market notification to the FDA pursuant to Section 510(k) of the U.S. Food, Drug and Cosmetic Act for its Yttrium-90 RadioGel™ patented brachytherapy cancer product.
Help employers find you! Check out all the jobs and post your resume.
comments powered by